A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial - PubMed (original) (raw)

Randomized Controlled Trial

A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial

Laura N Gitlin et al. JAMA. 2010.

Abstract

Context: Optimal treatment to postpone functional decline in patients with dementia is not established.

Objective: To test a nonpharmacologic intervention realigning environmental demands with patient capabilities.

Design, setting, and participants: Prospective 2-group randomized trial (Care of Persons with Dementia in their Environments [COPE]) involving patients with dementia and family caregivers (community-living dyads) recruited from March 2006 through June 2008 in Pennsylvania.

Interventions: Up to 12 home or telephone contacts over 4 months by health professionals who assessed patient capabilities and deficits; obtained blood and urine samples; and trained families in home safety, simplifying tasks, and stress reduction. Control group caregivers received 3 telephone calls and educational materials.

Main outcome measures: Functional dependence, quality of life, frequency of agitated behaviors, and engagement for patients and well-being, confidence using activities, and perceived benefits for caregivers at 4 months.

Results: Of 284 dyads screened, 270 (95%) were eligible and 237 (88%) randomized. Data were collected from 209 dyads (88%) at 4 months and 173 (73%) at 9 months. At 4 months, compared with controls, COPE patients had less functional dependence (adjusted mean difference, 0.24; 95% CI, 0.03-0.44; P = .02; Cohen d = 0.21) and less dependence in instrumental activities of daily living (adjusted mean difference, 0.32; 95% CI, 0.09-0.55; P = .007; Cohen d = 0.43), measured by a 15-item scale modeled after the Functional Independence Measure; COPE patients also had improved engagement (adjusted mean difference, 0.12; 95% CI, 0.07-0.22; P = .03; Cohen d = 0.26), measured by a 5-item scale. COPE caregivers improved in their well-being (adjusted mean difference in Perceived Change Index, 0.22; 95% CI, 0.08-0.36; P = .002; Cohen d = 0.30) and confidence using activities (adjusted mean difference, 0.81; 95% CI, 0.30-1.32; P = .002; Cohen d = 0.54), measured by a 5-item scale. By 4 months, 64 COPE dyads (62.7%) vs 48 control group dyads (44.9%) eliminated 1 or more caregiver-identified problems (chi(2/1) = 6.72, P = . 01).

Conclusion: Among community-living dyads, a nonpharmacologic biobehavioral environmental intervention compared with control resulted in better outcomes for COPE dyads at 4 months. Although no group differences were observed at 9 months for patients, COPE caregivers perceived greater benefits.

Trial registration: clinicaltrials.gov Identifier: NCT00259454.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Flowchart of Study Design Of the 102 dyads in the intervention group, 3 patients were placed in nursing homes and caregivers received a modified 4-month assessment. Of the 107 dyads in the control group, 4 patients were placed in nursing homes and caregivers received a modified 4-month assessment. MMSE indicates Mini-Mental State Examination.

Figure 2

Figure 2

Perceived Benefits of Intervention and Control Group Caregivers at 9 Months Percentages indicate those responding “yes” for Study Satisfaction items or “a great deal” for Caregiver or Patient Benefits items.

Comment in

Similar articles

Cited by

References

    1. 2010 Alzheimer’s disease facts and figures. Alzheimer’s Association. http://www.alz.org/documents_custom/report_alzfactsfigures2010.pdf. Accessed August 4, 2010. - PubMed
    1. Atchison TB, Massman PJ, Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer’s type. Arch Clin Neuropsychol. 2007;22(1):99–107. - PubMed
    1. Hill J, Fillit H, Thomas SK, Chang S. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer’s disease and other dementias. Pharmacoeconomics. 2006;24(3):265–280. - PubMed
    1. Soto ME, Andrieu S, Gillette-Guyonnet S, Cantet C, Nourhashemi F, Vellas B. Risk factors for functional decline and institutionalisation among community- dwelling older adults with mild to severe Alzheimer’s disease: one year of follow-up. Age Ageing. 2006;35(3):308–310. - PubMed
    1. Spillman BC, Long SK. Does high caregiver stress predict nursing home entry? Inquiry. 2009;46(2):140–161. - PubMed

Publication types

MeSH terms

LinkOut - more resources